Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Loading APPY News...
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | 0.96% | 73.42 | 0.9% | $713.07m | |
| AMGN | Amgen Inc. | 0.08% | 179.32 | 1.1% | $583.83m | |
| CELG | Celgene Corporation | 0.97% | 136.31 | 1.1% | $571.96m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.83% | 521.13 | 2.7% | $511.51m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.23% | 159.33 | 1.9% | $392.76m | |
| BIIB | Biogen Inc. | -0.18% | 281.44 | 1.2% | $388.90m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.97% | 129.81 | 1.9% | $272.80m | |
| TSRO | TESARO, Inc. | 4.02% | 129.01 | 14.7% | $168.19m | |
| INCY | Incyte Corporation | 2.56% | 133.79 | 2.6% | $164.97m | |
| ILMN | Illumina, Inc. | -1.10% | 171.97 | 3.5% | $156.83m | |
| EXEL | Exelixis, Inc. | 0.90% | 26.99 | 6.5% | $154.24m | |
| CLVS | Clovis Oncology, Inc. | 1.69% | 85.27 | 18.0% | $152.78m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.59% | 87.74 | 4.4% | $131.34m | |
| KITE | Kite Pharma, Inc. | 4.23% | 109.89 | 16.1% | $121.79m | |
| BLUE | Bluebird Bio, Inc. | -1.54% | 95.80 | 19.3% | $109.71m |
Company Profile
BiOptix, Inc. is a vitro diagnostic company. The company focuses on the commercializing of its blood-based test to serve as an adjunctive test in the diagnosis and treatment of acute appendicitis in children adolescent and young adult patients. The company was founded on July 24, 2000 and is headquartered in Boulder, CO.